Wednesday, 19 August 2026 · World
USD/EUR 0.8639 USD/GBP 0.7388 USD/JPY 159.6 USD/CNY 6.757 All rates →
RSS
EUROS The World Financial Report
Nº 39 Wednesday, 19 August 2026 · World Edition
LATEST
Companies

BioMarin is acquiring Alesta Therapeutics for $275 million to develop a first oral rare bone disease treatment

Quartz · 1h ago
BioMarin is acquiring Alesta Therapeutics for $275 million to develop a first oral rare bone disease treatment

The deal gives BioMarin access to ALE1, a small-molecule drug in early-stage trials that could become the first oral therapy for hypophosphatasia

Read the full story at Quartz →